Kolon TissueGene, Inc.
Kolon TissueGene, Inc.
Share · KR8840120008 (XKOS)
Overview
No Price
Closing Price XKOS 09.12.2025: 80.900,00 KRW
09.12.2025 06:30
Current Prices from Kolon TissueGene, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
950160.KQ
KRW
09.12.2025 06:30
80.900,00 KRW
3.600,00 KRW
+4,66 %
Company Profile for Kolon TissueGene, Inc. Share
Kolon TissueGene, Inc. is a biopharmaceutical company, which engages in the development of clinical-stage cell therapies for osteoarthritis. It offers TG-C, a platform technology that consists of a combination of allogeneic primary cells combined with genetically modified cells. The company was founded by Kwan H. Lee on June 9, 1999 and is headquartered in Rockville, MD.
Get up to date insights from finAgent about Kolon TissueGene, Inc.

Company Data

Name Kolon TissueGene, Inc.
Company Kolon TissueGene, Inc.
Primary Exchange XKOS KOSDAQ
ISIN KR8840120008
Asset Class Share
Sector Healthcare
Industry Biotechnology
Market Capitalization 6.638 Mrd.
Country United States of America
Currency KRW
Employees -
IPO Date 2017-11-06

Ticker Symbols

Name Symbol
KOSDAQ 950160.KQ
More Shares
Investors who hold Kolon TissueGene, Inc. also have the following shares in their portfolio:
LAMB WESTON HOLDINGS INC
LAMB WESTON HOLDINGS INC Share
SAMSONITE F. 25/33 REGS
SAMSONITE F. 25/33 REGS Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025